David Low
Stock Analyst at UBS
(3.46)
# 2,388
Out of 4,676 analysts
301
Total ratings
52.2%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ANN Ansell Limited | Maintained: Hold | $34.25 → $38.70 | $40.48 | -4.40% | 17 | Aug 25, 2026 | |
| ASX: REG Regis Healthcare Limited | Maintained: Hold | $7.00 → $6.75 | $6.13 | +10.11% | 15 | Aug 25, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $19.60 → $21.20 | $20.29 | +4.48% | 33 | Aug 21, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $106.00 → $150.00 | $137.43 | +9.15% | 22 | Aug 19, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $158.00 → $181.00 | $174.69 | +3.61% | 31 | Aug 19, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | n/a | $32.90 | - | 25 | Aug 7, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $42.90 | $43.96 | -2.41% | 20 | May 28, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Downgraded: Hold | $16.50 | $15.78 | +4.56% | 3 | Aug 31, 2025 | |
| ASX: PNV PolyNovo Limited | Maintained: Hold | $1.30 | $0.98 | +33.06% | 1 | Aug 27, 2025 | |
| NZE: EBO EBOS Group Limited | Maintained: Hold | $46.18 → $43.78 | $22.35 | +95.89% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4.00 → $3.90 | $2.90 | +34.48% | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.25 → $3.40 | $2.39 | +42.26% | 12 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.62 | $0.42 | n/a | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $282.00 → $300.00 | $185.70 | n/a | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $290 → $310 | $236.59 | n/a | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 32.00 → 35.00 | 44.96 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.95 → $0.78 | $0.29 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.77 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $31.23 | n/a | 1 | Dec 4, 2019 |
Ansell Limited
Aug 25, 2026
Maintained: Hold
Price Target: $34.25 → $38.70
Current: $40.48
Upside: -4.40%
Regis Healthcare Limited
Aug 25, 2026
Maintained: Hold
Price Target: $7.00 → $6.75
Current: $6.13
Upside: +10.11%
Sonic Healthcare Limited
Aug 21, 2026
Maintained: Hold
Price Target: $19.60 → $21.20
Current: $20.29
Upside: +4.48%
Cochlear Limited
Aug 19, 2026
Maintained: Hold
Price Target: $106.00 → $150.00
Current: $137.43
Upside: +9.15%
CSL Limited
Aug 19, 2026
Maintained: Buy
Price Target: $158.00 → $181.00
Current: $174.69
Upside: +3.61%
ResMed Inc.
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $32.90
Upside: -
Ramsay Health Care Limited
May 28, 2026
Maintained: Hold
Price Target: $42.90
Current: $43.96
Upside: -2.41%
Telix Pharmaceuticals Limited
Aug 31, 2025
Downgraded: Hold
Price Target: $16.50
Current: $15.78
Upside: +4.56%
PolyNovo Limited
Aug 27, 2025
Maintained: Hold
Price Target: $1.30
Current: $0.98
Upside: +33.06%
EBOS Group Limited
Aug 27, 2025
Maintained: Hold
Price Target: $46.18 → $43.78
Current: $22.35
Upside: +95.89%
Aug 27, 2025
Maintained: Sell
Price Target: $4.00 → $3.90
Current: $2.90
Upside: +34.48%
Aug 27, 2025
Maintained: Buy
Price Target: $3.25 → $3.40
Current: $2.39
Upside: +42.26%
Aug 25, 2025
Maintained: Sell
Price Target: $0.62
Current: $0.42
Upside: n/a
Aug 14, 2025
Maintained: Hold
Price Target: $282.00 → $300.00
Current: $185.70
Upside: n/a
Aug 1, 2025
Maintained: Buy
Price Target: $290 → $310
Current: $236.59
Upside: n/a
Jun 3, 2025
Maintained: Hold
Price Target: 32.00 → 35.00
Current: 44.96
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $0.95 → $0.78
Current: $0.29
Upside: n/a
Aug 23, 2021
Maintained: Hold
Price Target: n/a
Current: $14.77
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $31.23
Upside: n/a